Skip to content
DataLookout
Menu

Wang Fengmei clinical trial pipeline

Get alerts when Wang Fengmei's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-21

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  1. Notable: Daridorexant for Sleep Disturbance · Liver Cirrhosis Start date pushed from Sep 2026 to Dec 2026 Wang FengmeiPhase 4 NCT07830303
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Active trials by phase

Phase 4
1
Get alerts when Wang Fengmei's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free